# Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/activity-and-safety-of-crizotinib-in-patients-with-alk-positive-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | D. Ross Camidge,Yung‐Jue Bang,Eunice L. Kwak,A. John Iafrate,Marileila Varella‐Garcia,Stephen B. Fox,Gregory J. Riely,Benjamin Solomon,Sai‐Hong Ignatius Ou,Dong‐Wan Kim,Ravi Salgia,P. Fidias,Jeffrey A. Engelman,Leena Gandhi,Pasi A. Jänne,Daniel B. Costa,Geoffrey I. Shapiro,Patricia LoRusso,Katherine Ruffner,Patricia Stephenson,Yiyun Tang,Keith D. Wilner,Jeffrey W. Clark,Alice T. Shaw |
| Citations | 1,283 |
| DOI | 10.1016/s1470-2045(12)70344-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2134787029 |
| PMID | 22954507 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Jeffrey A. Engelman](https://scholariq.org/researchers/jeffrey-a-engelman/)
- [Benjamin Solomon](https://scholariq.org/researchers/benjamin-solomon/)
- [Pasi A. Jänne](https://scholariq.org/researchers/pasi-a-janne/)
- [A. John Iafrate](https://scholariq.org/researchers/a-john-iafrate/)
- [Gregory J. Riely](https://scholariq.org/researchers/gregory-j-riely/)
- [Dong‐Wan Kim](https://scholariq.org/researchers/dong-wan-kim/)
- [Ravi Salgia](https://scholariq.org/researchers/ravi-salgia/)
- [Alice T. Shaw](https://scholariq.org/researchers/alice-t-shaw/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.